Publications

  1. Anampa, J.D., et al., Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer. Clin Cancer Res, 2025. 31(2): p. 266-277. PMID: 39531537
  2. Duran, C.L., et al., Targeting CSF-1 signaling between tumor cells and macrophages at TMEM doorways inhibits breast cancer dissemination. Oncogene, 2025. PMID: 40646332
  3. Entenberg, D., M.H. Oktay, and J.S. Condeelis, Intravital imaging to study cancer progression and metastasis. Nat Rev Cancer, 2023. 23(1): p. 25-42. PMID: 36385560
  4. Linder, S., et al., Mechanisms and roles of podosomes and invadopodia. Nat Rev Mol Cell Biol, 2023. 24(2): p. 86-106. PMID: 36104625
  5. Dhainaut, M., et al., Spatial CRISPR genomics identifies regulators of the tumor microenvironment. Cell, 2022. 185(7): p. 1223-1239 e20. PMID: 35290801
  6. Di Martino, J.S., et al., A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nat Cancer, 2022. 3(1): p. 90-107. PMID: 35121989
  7. Fane, M.E., et al., Stromal changes in the aged lung induce an emergence from melanoma dormancy. Nature, 2022. 606(7913): p. 396-405. PMID: 35650435
  8. Grout, J.A., et al., Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors. Cancer Discov, 2022. 12(11): p. 2606-2625. PMID: 36027053
  9. Karagiannis, G.S., et al., Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy. NPJ Breast Cancer, 2022. 8(1): p. 101. PMID: 36056005
  10. Khalil, B.D., et al., An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy. J Exp Med, 2022. 219(1). PMID: 34812843
  11. Marron, T.U., et al., Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial. Lancet Gastroenterol Hepatol, 2022. 7(3): p. 219-229. PMID: 35065058
  12. Marron, T.U., et al., Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery. Nat Med, 2022. 28(4): p. 626-629. PMID: 35347282
  13. Nobre, A.R., et al., ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung. Nat Cancer, 2022. 3(10): p. 1165-1180. PMID: 36050483
  14. Rodriguez-Tirado, C., et al., Interleukin 4 Controls the Pro-Tumoral Role of Macrophages in Mammary Cancer Pulmonary Metastasis in Mice. Cancers (Basel), 2022. 14(17). PMID: 36077870
  15. Scheele, C., et al., Multiphoton intravital microscopy of rodents. Nat Rev Methods Primers, 2022. 2(1): p. 1-26. PMID: 37621948
  16. Entenberg, D., et al., Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM, a Prognostic Biomarker for Metastasis. Cancers (Basel), 2020. 12(4). PMID: 32244564
  17. Ginter, P.S., et al., Tumor Microenvironment of Metastasis (TMEM) Doorways Are Restricted to the Blood Vessel Endothelium in Both Primary Breast Cancers and Their Lymph Node Metastases. Cancers (Basel), 2019. 11(10): p. 1507. PMID: 31597373
  18. Karagiannis, G.S., et al., Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis. J Vis Exp, 2019. (148). PMID: 31305525
  19. Karagiannis, G.S., J.S. Condeelis, and M.H. Oktay, Chemotherapy-induced metastasis: mechanisms and translational opportunities. Clin Exp Metastasis, 2018. 35(4): p. 269-284. PMID: 29307118
  20. Pastoriza, J.M., et al., Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer. Clin Exp Metastasis, 2018. 35(7): p. 613-623. PMID: 30136072
  21. Harney, A.S., et al., The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2(Hi) Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors. Mol Cancer Ther, 2017. 16(11): p. 2486-2501. PMID: 28838996
  22. Karagiannis, G.S., et al., Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism. Sci Transl Med, 2017. 9(397). PMID: 28679654
  23. Sparano, J.A., et al., A metastasis biomarker (MetaSite Breast Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer. NPJ Breast Cancer, 2017. 3: p. 42. PMID: 29138761